Previous Article | Next Article ![]()
Journal of Clinical Microbiology, June 1999, p. 1892-1898, Vol. 37, No. 6
Département de Microbiologie
Médicale et Moléculaire, Unité de
Bactériologie, Centre Hospitalier Universitaire Bretonneau,
37044 Tours, France
Received 22 September 1998/Returned for modification 10 January
1999/Accepted 20 March 1999
A collection of 114 independent Streptococcus
agalactiae strains, including 54 strains isolated from the
cerebrospinal fluid (CSF) samples of neonates and 60 strains from
asymptomatic patients, was characterized by pulsed-field gel
electrophoresis (PFGE) of DNA restricted with SmaI and by
PCR analysis of the hylB gene. All strains were previously
studied by multilocus enzyme electrophoresis (MLEE) (R. Quentin, H. Huet, F.-S. Wang, P. Geslin, A. Goudeau, and R. K. Selander,
J. Clin. Microbiol. 33:2576-2581, 1995). Among these 114 strains,
there were 92 PFGE patterns. Eleven genetic groups (A to K) were
identified with 38% divergence. A more homogeneous group (PFGE group
A) was defined, consisting of 73% of the strains previously identified
as belonging to a particular MLEE phylogenetic group. A 162-kb fragment
was identified as a marker of strains that invaded the central nervous
system of neonates. It was detected in 69% of the PFGE patterns
obtained with CSF isolates and in only 1.8% of the PFGE patterns
obtained with carrier strains. The hylB gene encoding
hyaluronate lyase was amplified for all strains in our
collection. Ten of 15 isolates belonging to an MLEE
subgroup, previously described as being likely to cause
invasive infection, had an insertion in the hylB gene
(IS1548).
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Genetic Features of Streptococcus agalactiae Strains
Causing Severe Neonatal Infections, as Revealed by Pulsed-Field Gel
Electrophoresis and hylB Gene Analysis
*
Corresponding author. Mailing address:
Département de Microbiologie Médicale et Moléculaire,
Unité de Bactériologie, CHRU Bretonneau, 2 Bd.
Tonnellé, 37044 Tours Cedex, France. Phone: (33) 2 47 47 80 56. Fax: (33) 2 47 47 38 12. E-mail:
quentin{at}pop.med.univ-tours.fr.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|